These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14 related articles for article (PubMed ID: 4128407)
1. Comparison of the L-asparaginases from Escherichia coli and Erwinia carotovora as immunosuppressants. Ashworth LA; MacLennan AP Cancer Res; 1974 Jun; 34(6):1353-9. PubMed ID: 4596965 [No Abstract] [Full Text] [Related]
2. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Ohnuma T; Holland JF; Meyer P Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405 [No Abstract] [Full Text] [Related]
3. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase. Uren JR; Hargis BJ; Beardsley P Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004 [TBL] [Abstract][Full Text] [Related]
4. THE ROLE OF ANTIGEN DOSAGE IN DRUG-INDUCED IMMUNOLOGIC TOLERANCE. SCHWARTZ RS; DAMESHEK W J Immunol; 1963 May; 90():703-10. PubMed ID: 14053288 [No Abstract] [Full Text] [Related]
5. Cyclophosphamide-induced tolerance to equine globulin and to equine-anti-mouse-thymocyte globulin in adult mice. I. Studies on antigen and drug requirements. Stockman GD; Trentin JJ J Immunol; 1972 Jan; 108(1):112-8. PubMed ID: 4110794 [No Abstract] [Full Text] [Related]
6. Immunological tolerance to Erwinia carotovora L-asparaginase. Ashworth LA; Maclennan AP Int Arch Allergy Appl Immunol; 1973; 45(6):915-29. PubMed ID: 4128407 [No Abstract] [Full Text] [Related]